In-Licensing

We’re expanding our product portfolio

Exsilios is seeking to expand its product portfolio in Canada. Our business development activities are focused on branded prescription products that are in late-stage development, or currently approved and commercialized outside Canada, or approved in Canada but falling outside the license holder’s business focus. We will consider in-licensing, acquisition, co-promotion, revenue-sharing, and other partnering opportunities.

Therapeutic categories of primary interest for proprietary products include dermatology, neurology, psychiatry, pain management, and women's health, although we will consider other opportunities outside of these areas.

For partnering inquiries please contact us.